Please login to the form below

Not currently logged in
Email:
Password:

Optimum wins Silence Therapeutics account

The healthcare communications group will advise in financial PR

OptimumLondon, UK-based Optimum Strategic Communications has been appointed by RNAi-focused Silence Therapeutics.

Working with US strategic partner Burns McClellan, the healthcare communications group will develop and implement an investor relations and corporate communications programme for Silence Therapeutics.

Commenting on the appointments, Ali Mortazavi, chief executive officer of Silence Therapeutics, said:  “We wanted to work with a partner that could help us raise our profile in global investment community and build our reputation in the global life science industry.

“With its market-leading media relations expertise and unrivalled investor relations contacts, Optimum is the ideal partner to help us communicate our compelling equity story to the right healthcare investors.”

Since its launch in October 2017, Optimum has won over 20 clients in the life science and healthcare sectors.

Mary Clark, managing director of Optimum, said: “This is an exceptionally exciting time for Optimum and we are very excited to be working with Silence Therapeutics, which joins our growing client list of innovative and ambitious healthcare companies in the UK and across Europe.

“Our team’s knowledge of the global healthcare industry, combined with our understanding of the investor universe, enables us to provide our clients with an integrated service to help them achieve their goals.”

Article by
Gemma Jones

8th March 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics